You might have heard about the alarming situation, which is being prevailed across UK because of the increasing cases of Parkinson’s disease in this part of the world. Right now, the number of patients of this disease is too high in UK. Medical and scientific researchers are working hard to apply stem cell technology on the patients so that they could treat their disease in safe way. It is Oxford Parkinson’s Disease Center, where efforts are being made in the form of advancement in the field of IPS cell technology. They are trying to make their research even better so that they could use this technology safely on Parkinson’s patients. The best part about the advancement in the field of stem cell technology is that this research is being fully supported by public and private sector. Oxford Parkinson’s Disease Center is receiving considerable about of funds and grants, which are being used for the development of skin-cell-to-brain-cell research program.
The work, researches and studies that have been conducted so far, have helped the researchers to know that this disease is caused when dopamine cells are dead in the body. Now, the researchers take skin cells of the patients and then the cells are concerted into induced pluripotent stem cells. These converted cells are later on converted into dopamine neurons, which are helpful and effective for giving the right treatment to the patients. The reason why skin samples are taken instead of doing brain biopsy of Parkinson’s disease patients is that taking samples is easier and safer for the patients. Moreover, this process gives better and accurate results. When the neurons of patients and non patients are taken and compared, then researchers come to know the reasons due to which dopamine neurons die. Now, Wade-Martins and his team are planning something that would support this research like never before. They are planning to use their Monument Discovery Award for the purpose of doing research on IPS cells technology for the coming 5 years.
provide Custom IPS cells – Transposagen’s exclusive technologies piggyback and rat spermatogonial stem cells (SSCs)